-+ 0.00%
-+ 0.00%
-+ 0.00%

Co-Diagnostics teams with ReadyGo to evaluate blood-based PCR testing for decentralized Ebola detection

PUBT·09/16/2026 12:45:36
Listen to the news
Co-Diagnostics teams with ReadyGo to evaluate blood-based PCR testing for decentralized Ebola detection
  • Co-Diagnostics entered a collaboration with ReadyGo Diagnostics to evaluate blood-based molecular testing at the point of need, starting with Ebola.
  • Work targets compatibility between ReadyGo’s GoCollect blood sample-prep system and the Co-Dx PCR platform for decentralized outbreak detection.
  • Successful blood sample support could expand the platform beyond swabs into larger markets such as HIV and hepatitis B and C testing.
  • Feasibility testing has begun, with Co-Diagnostics taking delivery of ReadyGo devices and materials for workflow integration evaluation.
  • Co-Dx plans to discuss the collaboration in a live press conference and webcast at 10:30 a.m. ET today.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609160845PR_NEWS_USPR_____LA49138) on September 16, 2026, and is solely responsible for the information contained therein.